DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Ductal Carcinoma in Situ
Interventions: DRUG: Tamoxifen|DRUG: Exemestane|DRUG: Letrozole|DRUG: Anastrazole|DRUG: Testosterone + Anastrazole|DRUG: Elacestrant|DRUG: Z-endoxifen
Sponsor: QuantumLeap Healthcare Collaborative